atlanthera-clinical-phase-osteosarcoma

24-01- 2017
Atlanthera is now preparing its first clinical tests on patients for the end of the year 2017. Phase I tests for its drug candidate for osteosarcoma, rare bone cancer. Atlanthera should get the ANSM authorisation from september 2017. First clinical tests have already been conducted in 2016 on big dogs in collaboration with ONcovet research, Lille (North of France) confirming really promising efficacy…
A funds raising is under process and soon closed to finance this next regulatory step…
Read the article (in French) >